Chi B. Vu
Department of Medicinal Chemistry
Biogen Idec
Inc., 14 Cambridge Center
Cambridge
USA
Name/email consistency: high
- Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. Vu, C.B., Pan, D., Peng, B., Kumaravel, G., Smits, G., Jin, X., Phadke, D., Engber, T., Huang, C., Reilly, J., Tam, S., Grant, D., Hetu, G., Petter, R.C. J. Med. Chem. (2005)
- Recent advances in the design and optimization of adenosine A2A receptor antagonists. Vu, C.B. Curr. Opin. Drug. Discov. Devel (2005)
- Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. Vu, C.B., Peng, B., Kumaravel, G., Smits, G., Jin, X., Phadke, D., Engber, T., Huang, C., Reilly, J., Tam, S., Grant, D., Hetu, G., Chen, L., Zhang, J., Petter, R.C. J. Med. Chem. (2004)
- Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles. Vu, C.B., Pan, D., Peng, B., Sha, L., Kumaravel, G., Jin, X., Phadke, D., Engber, T., Huang, C., Reilly, J., Tam, S., Petter, R.C. Bioorg. Med. Chem. Lett. (2004)
- Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists. Vu, C.B., Shields, P., Peng, B., Kumaravel, G., Jin, X., Phadke, D., Wang, J., Engber, T., Ayyub, E., Petter, R.C. Bioorg. Med. Chem. Lett. (2004)
